| For: |
Qiu JF, Zhang ZQ, Chen W, Wu ZY. Cystamine ameliorates liver fibrosis induced by carbon tetrachloride |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i32/4328.htm |
| Number | Citing Articles |
| 1 |
Dmitry S. Semenovich, Polina A. Abramicheva, Ljubava D. Zorova, Andrey V. Elchaninov, Maria A. Kozlova, David A. Areshidze, Nadezda V. Andrianova, Nina P. Kanunnikova, Andrey G. Moiseenok, Irina B. Pevzner, Egor Y. Plotnikov, Dmitry B. Zorov. Pantothenic Acid Derivatives Modulate Oxidative Stress and Hepatic Fibrosis in Bile Duct Ligation-Induced Cholestatic Liver Injury. Pathophysiology 2026; 33(2) doi: 10.3390/pathophysiology33020032
|
| 2 |
Yirong Ding, Ji Zhang, Rui Wang. Inhibition of tissue transglutaminase attenuates lipopolysaccharide-induced inflammation in glial cells through AKT/mTOR signal pathway. Biomedicine & Pharmacotherapy 2017; 89 doi: 10.1016/j.biopha.2017.03.027
|
| 3 |
Keith C. Olsen, Amali P. Epa, Ajit A. Kulkarni, R. Matthew Kottmann, Claire E. McCarthy, Gail V. Johnson, Thomas H. Thatcher, Richard P. Phipps, Patricia J. Sime. Inhibition of Transglutaminase 2, a Novel Target for Pulmonary Fibrosis, by Two Small Electrophilic Molecules. American Journal of Respiratory Cell and Molecular Biology 2014; 50(4) doi: 10.1165/rcmb.2013-0092OC
|
| 4 |
Keith C. Olsen, Ramil E. Sapinoro, R. M. Kottmann, Ajit A. Kulkarni, Siiri E. Iismaa, Gail V. W. Johnson, Thomas H. Thatcher, Richard P. Phipps, Patricia J. Sime. Transglutaminase 2 and Its Role in Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 2011; 184(6) doi: 10.1164/rccm.201101-0013OC
|
| 5 |
Ting Guo, Cindy Wantono, Yuyong Tan, Feihong Deng, Tianying Duan, Deliang Liu. Regulators, functions, and mechanotransduction pathways of matrix stiffness in hepatic disease. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1098129
|
| 6 |
Shunnosuke Kunoki, Masashi Ikeno, Hideki Tatsukawa, Yukinao Sakai, Hiroshi Kinashi, Keisuke Kamiya, Masafumi Suzuki, Masashi Mizuno, Makoto Yamaguchi, Hiroyuki Sasakura, Yuki Morioka, Masataka Banshodani, Mitsuhiro Tawada, Masato Iwabu, Takuji Ishimoto, Kosei Takeuchi, Kiyotaka Hitomi, Hideki Kawanishi, Yasuhiko Ito. Transglutaminase 2 in human peritoneal dialysis‐related peritoneal injury. Physiological Reports 2025; 13(18) doi: 10.14814/phy2.70567
|
| 7 |
Je Hyeong Kim. The Role of Transglutaminase-2 in Fibroproliferation after Lipopolysaccharide-induced Acute Lung Injury. Tuberculosis and Respiratory Diseases 2010; 69(5) doi: 10.4046/trd.2010.69.5.337
|
| 8 |
Giuseppe D’Argenio, Daniela Caterina Amoruso, Giovanna Mazzone, Paola Vitaglione, Antonietta Romano, Maria Teresa Ribecco, Maria Rosaria D’Armiento, Ernesto Mezza, Filomena Morisco, Vincenzo Fogliano, Nicola Caporaso. Garlic extract prevents CCl4-induced liver fibrosis in rats: The role of tissue transglutaminase. Digestive and Liver Disease 2010; 42(8) doi: 10.1016/j.dld.2009.11.002
|
| 9 |
Theerut Luangmonkong, Warisara Parichatikanond, Peter Olinga. Targeting collagen homeostasis for the treatment of liver fibrosis: Opportunities and challenges. Biochemical Pharmacology 2023; 215 doi: 10.1016/j.bcp.2023.115740
|
| 10 |
Liming Liu, Ying Zhou, Dan Dai, Hongmei Xia, Kang Zhao, Jianjun Zhang, Samuel Martins Silvestre. Antifibrotic Effects of Kangxian Ruangan Capsule on Rats with Nonalcoholic Fatty Liver Fibrosis and Hepatic Stellate Cells through Regulation of TGF-β and TLR4 Signaling Pathways. Evidence-Based Complementary and Alternative Medicine 2021; 2021 doi: 10.1155/2021/5649575
|
| 11 |
Kempaiah Rayavara, Alexander Kurosky, Yashoda M. Hosakote. Respiratory syncytial virus infection induces the release of transglutaminase 2 from human airway epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology 2022; 322(1) doi: 10.1152/ajplung.00013.2021
|
| 12 |
Hideki Tatsukawa, Kiyotaka Hitomi. Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis. Cells 2021; 10(7) doi: 10.3390/cells10071842
|
| 13 |
Ting Wang, Yan Duan, Dong Liu, Gang Li, Bin Liu. The effect of transglutaminase-2 inhibitor on pulmonary vascular remodeling in rats with pulmonary arterial hypertension. Clinical and Experimental Hypertension 2022; 44(2) doi: 10.1080/10641963.2021.2013493
|
| 14 |
Doa'a G.F. Al-U'datt, Carole C. Tranchant, Muhammad Alu'datt, Sara Abusara, Ahmed Al-Dwairi, Mohammad AlQudah, Othman Al-shboul, Roddy Hiram, Yasemin Altuntas, Saied Jaradat, Karem H. Alzoubi. Inhibition of transglutaminase 2 (TG2) ameliorates ventricular fibrosis in isoproterenol-induced heart failure in rats. Life Sciences 2023; 321 doi: 10.1016/j.lfs.2023.121564
|
| 15 |
Hideki Tatsukawa, Soichi Kojima. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis. Cell Biology International 2010; 34(3) doi: 10.1042/CBI20090130
|
| 16 |
Chunxiao Qi, Yaqian Li, Patrick Badger, Hongsheng Yu, Zhifeng You, Xiaojun Yan, Wei Liu, Yan Shi, Tie Xia, Jiahong Dong, Chenyu Huang, Yanan Du. Pathology-targeted cell delivery via injectable micro-scaffold capsule mediated by endogenous TGase. Biomaterials 2017; 126 doi: 10.1016/j.biomaterials.2017.02.021
|
| 17 |
Soichi Kojima, Ting‐Fang Kuo, Hideki Tatsukawa. Regulation of transglutaminase‐mediated hepatic cell death in alcoholic steatohepatitis and non‐alcoholic steatohepatitis. Journal of Gastroenterology and Hepatology 2012; 27(s2) doi: 10.1111/j.1440-1746.2011.07009.x
|
| 18 |
Juanjuan Tang, Huayi Huang, Xiaofang Ji, Xunmin Zhu, Yinyan Li, Mingmin She, Suikai Yan, Mingchiu Fung, Zi Li. Involvement of IL-13 and Tissue Transglutaminase in Liver Granuloma and Fibrosis afterSchistosoma japonicumInfection. Mediators of Inflammation 2014; 2014 doi: 10.1155/2014/753483
|
| 19 |
Nahla E El‐Ashmawy, Hoda A El‐Bahrawy, Maha M Shamloula, Amera O Ibrahim. Antifibrotic effect of AT‐1 blocker and statin in rats with hepatic fibrosis. Clinical and Experimental Pharmacology and Physiology 2015; 42(9) doi: 10.1111/1440-1681.12446
|
| 20 |
Doa'a G.F. Al-U'datt, Carole C. Tranchant, Ahmed Al-Dwairi, Mohammad Alqudah, Othman Al-Shboul, Roddy Hiram, Bruce G. Allen, Saied Jaradat, Jenan Alqbelat, Ahmed S. Abu-zaiton. Implications of enigmatic transglutaminase 2 (TG2) in cardiac diseases and therapeutic developments. Biochemical Pharmacology 2022; 201 doi: 10.1016/j.bcp.2022.115104
|
| 21 |
Deborah L Clarke, Alan M Carruthers, Tomas Mustelin, Lynne A Murray. Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes. Fibrogenesis & Tissue Repair 2013; 6(1) doi: 10.1186/1755-1536-6-20
|
| 22 |
E. A. M. Verderio, A. Scarpellini, T. S. Johnson. Novel interactions of TG2 with heparan sulfate proteoglycans: reflection on physiological implications. Amino Acids 2009; 36(4) doi: 10.1007/s00726-008-0134-6
|
| 23 |
L. Elli, C.M. Bergamini, M.T. Bardella, D. Schuppan. Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver. Digestive and Liver Disease 2009; 41(8) doi: 10.1016/j.dld.2008.12.095
|
| 24 |
Nooshin Daneshpour, Martin Griffin, Russell Collighan, Yvonne Perrie. Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis. Journal of Drug Targeting 2011; 19(8) doi: 10.3109/1061186X.2010.531731
|